Please login to the form below

Not currently logged in
Email:
Password:

Vernalis Therapeutics appoints president and COO

Sandford Sommer brings experience from AstraZeneca

UK-based Vernalis Therapeutics has appointed Sandford Sommer as its new president and chief operating officer.

Ian Garland, chief executive of Vernalis, said: “We are delighted to welcome Sandy to Vernalis at this exciting time as we build our US commercial operations.

“Sandy's depth of experience in sales and marketing, as well as in general management, make him ideally qualified to lead our US operations through this critical period of multiple product launches and rapid growth.”

Sommer joins the development stage pharmaceutical company from AstraZeneca, where he has spent the past 24 years in a series of increasingly senior roles.

Most recently, Sommer served as country president for AstraZeneca's operations in Colombia and prior to that was global vice president, CNS.

He has also served on the board of the UK Columbia Trade organisation since March 2014.

Sommer said: “I am excited to be joining Vernalis at such an important time.

“I am looking forward to the opportunity to contribute to the growth of the company's US business and to help rapidly advance the company's promising pipeline.”

3rd May 2016

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
StratX

StratX creates experiential learning programs instilled with emotion and competitive spirit, leading to lasting on-the-job change. Our memorable approach develops...

Latest intelligence

Medical information in precision medicine
Global Medical Information Leader James Oughton reveals the top trends in medical information and precision medicine....
Australian Flu and the dilemma of naming diseases
...
Wearables and Healthcare
What place do wearables have in affecting actual patient health outcomes and can they contribute to the NHS’s sustainability agenda? Or are they just the latest fad?...

Infographics